THe European Medicines Agency committee announced a positive opinion recommending romosozumab for the treatment of severe osteoporosis in postmenopausal women at high Fracture risk for fracture w/ no hx of MI/CVA https://t.co/sr7iPaSngj
Links:
European agency reconsiders, recommends romosozumab for fracture prevention
http://bit.ly/2MYc5V5
Oct-21-2019
